TY - JOUR
T1 - Effect of glycine and glycine receptor antagonists on NMDA-induced brain injury
AU - Uckele, John E.
AU - McDonald, John W.
AU - Johnston, Michael V.
AU - Silverstein, Faye S.
PY - 1989/12/15
Y1 - 1989/12/15
N2 - In postnatal day 7 rats, a unilateral intrastriatal injection of 12.5 nmol of N-methyl-d-aspartate (NMDA) reproducibly injures the ipsilateral striatum, adjacent hippocampus and overlying cortex. The severity of injury can be quantified by comparing cerebral hemisphere weights in animals sacrificed 5 days after the injection. Co-injection of NMDA and the glycine receptor antagonists kynurenic acid (KYN) or 7-chlorokynurenic acid (7-CKA) reduced the severity of NMDA-induced damage in a dose-dependent fashion. One hundred nmol of KYN with 12.5 nmol of NMDA reduced average % damage from 19.3±0.9% (n=9) to 2.3±0.5% (n=6), P<0.001, ANOVA. Co-injection of 40 nmol of 7-CKA with 12.5 nmol of NMDA (n=6) reduced average % damage from 17.1±1.6% (n=15) to 3.0±0.6%, P<0.001, ANOVA. Concurrent injection of 1000 nmol glycine with 5 nmol NMDA did not increase the extent of NMDA-induced damage. Our results demonstrate that glycine receptor antagonists attenuate NMDA-induced brain injury in vivo.
AB - In postnatal day 7 rats, a unilateral intrastriatal injection of 12.5 nmol of N-methyl-d-aspartate (NMDA) reproducibly injures the ipsilateral striatum, adjacent hippocampus and overlying cortex. The severity of injury can be quantified by comparing cerebral hemisphere weights in animals sacrificed 5 days after the injection. Co-injection of NMDA and the glycine receptor antagonists kynurenic acid (KYN) or 7-chlorokynurenic acid (7-CKA) reduced the severity of NMDA-induced damage in a dose-dependent fashion. One hundred nmol of KYN with 12.5 nmol of NMDA reduced average % damage from 19.3±0.9% (n=9) to 2.3±0.5% (n=6), P<0.001, ANOVA. Co-injection of 40 nmol of 7-CKA with 12.5 nmol of NMDA (n=6) reduced average % damage from 17.1±1.6% (n=15) to 3.0±0.6%, P<0.001, ANOVA. Concurrent injection of 1000 nmol glycine with 5 nmol NMDA did not increase the extent of NMDA-induced damage. Our results demonstrate that glycine receptor antagonists attenuate NMDA-induced brain injury in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0024971828&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024971828&partnerID=8YFLogxK
U2 - 10.1016/0304-3940(89)90831-8
DO - 10.1016/0304-3940(89)90831-8
M3 - Article
C2 - 2694024
AN - SCOPUS:0024971828
SN - 0304-3940
VL - 107
SP - 279
EP - 283
JO - Neuroscience Letters
JF - Neuroscience Letters
IS - 1-3
ER -